The angiosuppressive effects of 20(R)- ginsenoside Rg3

Liu, 1992, Recent advances on ginseng research in China, J Ethnopharmacol, 36, 27, 10.1016/0378-8741(92)90057-X Surh, 2001, Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C A. Meyer, J Korean Med Sci, 16, S38, 10.3346/jkms.2001.16.S.S38 Mochizuki, 1995, Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20 (R) – and 20 (R) – ginsenoside-Rg3, of Red ginseng, Biol Pharm Bull, 18, 1197, 10.1248/bpb.18.1197 Shinkai, 1996, Inhibitory of in vitro tumor cell invasion by ginsenoside Rg3, Jpn J Cancer Res, 87, 357, 10.1111/j.1349-7006.1996.tb00230.x Liu, 2000, Anti-proliferative effect of ginseng saponins on human prostate cancer cell line, Life Sci, 67, 1297, 10.1016/S0024-3205(00)00720-7 Yun, 2001, Anticarcinogenic effect of Panax ginseng C A. Meyer and identification of active compounds, J Korean Med Sci, 16, S6, 10.3346/jkms.2001.16.S.S6 Tao, 2002, Effect of angiogenesis inhibitor Rg3 on the growth and metastasis of gastric cancer in SCID mice, Zhounghua Wai Ke Za Zhi, 40, 606 Folkman, 1992, Angiogenesis J Biol Chem, 267, 10931, 10.1016/S0021-9258(19)49853-0 Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, 27, 10.1038/nm0195-27 Risau, 1997, Mechanisms of angiogenesis, Nature, 386, 671, 10.1038/386671a0 Walsh, 1999, Angiogenesis and arthritis, Rheumatology, 38, 103, 10.1093/rheumatology/38.2.103 Tonnesen, 2000, Angiogenesis in wound healing, J Investig Dermatol Symp Proc, 5, 40, 10.1046/j.1087-0024.2000.00014.x Favier, 2001, Physiological angiogenesis, Therapie, 56, 455 Folkman, 1974, Tumor angiogenesis, Adv Cancer Res, 19, 331, 10.1016/S0065-230X(08)60058-5 Eskens, 2004, Angiogenesis inhibitors in clinical development; where are we now and where are we going?, Br J Cancer, 90, 1, 10.1038/sj.bjc.6601401 Hori, 1994, Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells, Biochem Biophys Res Commun, 204, 1067, 10.1006/bbrc.1994.2571 Masiero, 1997, New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide TNP-470 and interleukin-12, Angiogenesis, 1, 23, 10.1023/A:1018301031580 Kohn, 1998, Endostatin and angiostatin: the next anti-angiogenesis generation, Angiogenesis, 2, 25, 10.1023/A:1009046208807 Doggrell, 2005, Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration, Expert Opin Pharmacother, 6, 1421, 10.1517/14656566.6.8.1421 Sengupta, 2004, Modulating angiogenesis: the yin and the yang in ginseng, Circulation, 10, 1219, 10.1161/01.CIR.0000140676.88412.CF Yue, 2005, Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg1 in vivo and in vitro, Angiogenesis, 8, 205, 10.1007/s10456-005-9000-2 Chen, 2005, The effect of 20(R)-ginsenoside Rg3 on the differential expression of cell signaling genes and other related genes in human lung adenocarcinoma cell line A549, Zhonghua Jie He He Hu Xi Za Zhi, 28, 37 Pan, 2002, Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma, Zhonghua Fu Chan Ke Za Zhi, 37, 227 Herron, 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors, J Biol Chem, 261, 2814, 10.1016/S0021-9258(17)35860-X Liotta, 1986, Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture, Cancer Res, 46, 1 Rabbani, 1998, Metalloproteases and urokinase in angiogenesis and tumor progression, In Vivo, 12, 135 Kahari, 1999, Matrix metalloproteinases and their inhibitors in tumour growth and invasion, Ann Med, 31, 34, 10.3109/07853899909019260 Fan, 1995, Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy, Trends Pharmacol Sci, 16, 57, 10.1016/S0165-6147(00)88979-8 Isner, 1998, Therapeutic angiogenesis, Front Biosci, 3, e49, 10.2741/A367 Longo, 2002, Anti-angiogenic therapy: rationale, challenges and clinical studies, Angiogenesis, 5, 237, 10.1023/A:1024532022166 Paper, 1998, Natural products as angiogenesis inhibitors, Planta Med, 64, 686, 10.1055/s-2006-957559 Singh, 2003, Tumor angiogenesis: a potential target in cancer control by phytochemicals, Curr Cancer Drug Targets, 3, 205, 10.2174/1568009033481985